3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
40
Triple Negative Breast Neoplasms
16
Carcinoma, Transitional Cell
14
Breast Neoplasms
14
Small Cell Lung Carcinoma
12
Urinary Bladder Neoplasms
11
Melanoma
10
Carcinoma, Hepatocellular
9
Neoplasms
8
Carcinoma, Renal Cell
8
Uterine Cervical Neoplasms
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Colorectal Neoplasms
5
Ovarian Neoplasms
4
Lymphoma, Follicular
4
Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Cholangiocarcinoma
3
Brain Neoplasms
3
Stomach Neoplasms
2
Solid Tumors
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Kidney Neoplasms
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Interventions
Cisplatin
4
Pemetrexed
3
Etoposide
3
Topotecan
2
Gemcitabine
2
Carboplatin
2
vosaroxin
1
vinflunine
1
veliparib
1
taxane
1
pomalidomide
1
pembrolizumab
1
liposomal doxorubicin
1
etoposide phosphate
1
enzalutamide
1
apalutamide
1
abiraterone
1
Vinorelbine
1
Tomography, X-Ray Computed
1
Temozolomide
1
Radiation
1
RRx-001
1
Positron-Emission Tomography
1
Podophyllotoxin
1
Platinum
1
Paclitaxel
1
Irinotecan
1
Histamine Antagonists
1
GSK2879552
1
Epinephrine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Small Cell
×
atezolizumab
×
Clear all
No trials found.